New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 29, 2013
16:31 EDTDEPODepomed files patent infringement suit against Purdue Pharma
Depomed disclosed in a regulatory filing that on January 29, Depomed filed a complaint in the United States District Court for the District of New Jersey against Purdue Pharma and affiliated companies for infringement of U.S. Patent Nos. 6,340,475; 6,635,280; and 6,723,340. The complaint alleges infringement of the Depomed patents arising from Purdue’s commercialization of OxyContin in the United States. The Depomed patents relate to Depomed’s Acuform drug delivery technology. U.S. Patent Nos. 6,340,475 and 6,635,280 will expire in 2016, and U.S. Patent No. 6,723,340 will expire in 2021.
News For DEPO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
11:01 EDTDEPODepomed management to meet with Piper Jaffray
Subscribe for More Information
07:21 EDTDEPOUBS to hold a conference
Subscribe for More Information
May 13, 2015
08:43 EDTDEPODepomed weakness overdone, says Roth Capital
Subscribe for More Information
May 12, 2015
12:44 EDTDEPODepomed selloff an overreaction, says Roth Capital
Subscribe for More Information
12:24 EDTDEPODepomed upgraded to Buy from Neutral at Janney Capital
Subscribe for More Information
09:20 EDTDEPOOn The Fly: Pre-market Movers
Subscribe for More Information
May 11, 2015
16:35 EDTDEPODepomed sees 2015 sales $310M-$335M, consensus $305M
Subscribe for More Information
16:34 EDTDEPODepomed reports Q1 adjusted EPS (13c), consensus 1c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use